GOSSAMER BIO INC

Gossamer Bio (GOSS) jumps 13.64% as investors eye its biopharma pipeline, yet its 200‑day SMA shows a steep gap—find out what this rally means for the stock’s future.

Gossamer Bio slides 3.9% after a steep 25% decline, trading deep below its 52‑week high with weak liquidity and unclear pipeline, raising investor caution.